The "send me my password" on the IBM Easy400 site is not working either. I
requested
once when this all started, and again this eve. No response.
I do hope this all get worked out for the benefit of the community.
jim franz

----- Original Message ----- 
From: "Jon Paris" <Jon.Paris@xxxxxxxxxxxxxx>
To: "web400" <web400@xxxxxxxxxxxx>
Sent: Monday, July 18, 2005 11:39 PM
Subject: [WEB400] CGIDEV2


> Just in case you haven't seen the news yet.  IBM have (partially) pulled
the
> plug on the Easy400 web site - home of CGIDEV2.
>
> Giovanni is continuing the tutorials, and distribution of all the other
> utilities from his new site (www.easy400.net) but IBM have apparently
> refused to allow him to distribute CGIDEV2.  Goodness knows why.  The
> license statement on the web site clearly says you can distribute
derivative
> works but ... they say no.
>
> On IBM's own site the download is still available, but it is clearly
marked
> as "frozen".
>
> Not a good day for the future of the iSeries.  If some idiot at IBM thinks
> this will make scores of people rush to WebSphere - well boy are they in
for
> a shock!  Just sit back now and wait for ASNA's advertisements pointing
out
> to people that IBM is obviously abandoning RPGers.
>
> Jon Paris
> Partner400
>
> www.Partner400.com
> www.RPGWorld.com
>
> -- 
> This is the Web Enabling the AS400 / iSeries (WEB400) mailing list
> To post a message email: WEB400@xxxxxxxxxxxx
> To subscribe, unsubscribe, or change list options,
> visit: http://lists.midrange.com/mailman/listinfo/web400
> or email: WEB400-request@xxxxxxxxxxxx
> Before posting, please take a moment to review the archives
> at http://archive.midrange.com/web400.
>
>



This thread ...

Follow-Ups:
Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].